Aktie A2PAUE THC THERAPEUTICS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen THC Therapeutics, Inc.

Aktien

A2PAUE

US87248Q1013

THCT

Markt geschlossen - OTC Markets
Andere Börsenplätze
 21:17:39 23.05.2024 		% 5 Tage % 1. Jan.
0,0033 USD 0,00 % Intraday Chart für THC Therapeutics, Inc. 0,00 % 0,00 %
26.02. THC Therapeutics, Inc. meldet Ergebnis für das am 31. Juli 2023 endende Geschäftsjahr CI
09.01. THC Therapeutics, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. April 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
THC Therapeutics, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023
THC Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
THC Therapeutics, Inc., Appoints Scott Cox as A Member of Its Board of Directors
THC Therapeutics, Inc. Announces CEO Changes
THC THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
THC Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022
THC Therapeutics, Inc. Reports Earnings Results for the Full Year Ended July 31, 2022
THC THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)
THC Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
THC THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
THC Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022
THC THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
THC Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022
THC Therapeutics, Inc. Reports Earnings Results for the Full Year Ended July 31, 2021
THC THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)
THC Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
THC THERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
THC THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
THC THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
THC Therapeutics, Inc. Announces Resignation of Joshua Halford as Director and Chief Operating Officer
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PAUE Aktie
  4. Nachrichten THC Therapeutics, Inc.
  5. Andere Sprachen